CSF2 and neoplasm: T-VEC is an oncolytic herpes simplex virus modified to proliferate only in tumor cells and carry the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene [3].The GM-CSF produced in the tumor microenvironment induces tumor-specific immunity through the presentation of released tumor antigens by dendritic cells attracted via GM-CSF.